Dual role of fatty acid-binding protein 5 on endothelial cell fate: a potential link between lipid metabolism and angiogenic responses

详细信息    查看全文

• 作者：Chen-Wei Yu ; Xiaoliang Liang ; Samantha Lipsky ; Cagatay Karaaslan…
• 关键词：FABP4 ; FABP5 ; Angiogenesis ; Endothelial cell ; PPAR ; Apoptosis ; Cell survival ; Aortic ring assay
• 刊名：Angiogenesis
• 出版年：2016
• 出版时间：January 2016
• 年：2016
• 卷：19
• 期：1
• 页码：95-106
• 全文大小：5,113 KB
• 参考文献：1.Hertzel AV, Bernlohr DA (2000) The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends Endocrinol Metab 11:175–180PubMed CrossRef
  2.Makowski L, Hotamisligil GS (2005) The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis. Curr Opin Lipidol 16:543–548PubMed PubMedCentral CrossRef
  3.Smathers RL, Petersen DR (2011) The human fatty acid-binding protein family: evolutionary divergences and functions. Hum Genomics 5:170–191PubMed PubMedCentral CrossRef
  4.Furuhashi M, Ishimura S, Ota H, Miura T (2011) Lipid chaperones and metabolic inflammation. Int J Inflam 2011:642612PubMed PubMedCentral
  5.Storch J, Thumser AE (2010) Tissue-specific functions in the fatty acid-binding protein family. J Biol Chem 285:32679–32683PubMed PubMedCentral CrossRef
  6.Richieri GV, Ogata RT, Zimmerman AW, Veerkamp JH, Kleinfeld AM (2000) Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions. Biochemistry 39:7197–7204PubMed CrossRef
  7.Cataltepe O, Arikan MC, Ghelfi E, Karaaslan C, Ozsurekci Y et al (2012) Fatty acid binding protein 4 is expressed in distinct endothelial and non-endothelial cell populations in glioblastoma. Neuropathol Appl Neurobiol 38:400–410PubMed CrossRef
  8.Cataltepe S, Arikan MC, Liang X, Smith TW, Cataltepe O (2015) Fatty acid binding protein 4 expression in cerebral vascular malformations: implications for vascular remodelling. Neuropathol Appl Neurobiol 41:646–656PubMed CrossRef
  9.Elmasri H, Ghelfi E, Yu CW, Traphagen S, Cernadas M et al (2012) Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway. Angiogenesis 15:457–468PubMed PubMedCentral CrossRef
  10.Elmasri H, Karaaslan C, Teper Y, Ghelfi E, Weng M et al (2009) Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J 23:3865–3873PubMed PubMedCentral CrossRef
  11.Ghelfi E, Yu CW, Elmasri H, Terwelp M, Lee CG et al (2013) Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma. Am J Pathol 182:1425–1433PubMed PubMedCentral CrossRef
  12.Masouye I, Hagens G, Van Kuppevelt TH, Madsen P, Saurat JH et al (1997) Endothelial cells of the human microvasculature express epidermal fatty acid-binding protein. Circ Res 81:297–303PubMed CrossRef
  13.Iso T, Maeda K, Hanaoka H, Suga T, Goto K et al (2013) Capillary endothelial fatty acid binding proteins 4 and 5 play a critical role in fatty acid uptake in heart and skeletal muscle. Arterioscler Thromb Vasc Biol 33:2549–2557PubMed PubMedCentral CrossRef
  14.Madsen P, Rasmussen HH, Leffers H, Honore B, Celis JE (1992) Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. J Invest Dermatol 99:299–305PubMed CrossRef
  15.Ghelfi E, Karaaslan C, Berkelhamer S, Akar S, Kozakewich H et al (2011) Fatty acid-binding proteins and peribronchial angiogenesis in bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 45:550–556PubMed PubMedCentral CrossRef
  16.Maeda K, Uysal KT, Makowski L, Gorgun CZ, Atsumi G et al (2003) Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes 52:300–307PubMed PubMedCentral CrossRef
  17.Siegenthaler G, Hotz R, Chatellard-Gruaz D, Didierjean L, Hellman U et al (1994) Purification and characterization of the human epidermal fatty acid-binding protein: localization during epidermal cell differentiation in vivo and in vitro. Biochem J 302(Pt 2):363–371PubMed PubMedCentral CrossRef
  18.Furuhashi M, Fucho R, Gorgun CZ, Tuncman G, Cao H et al (2008) Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest 118:2640–2650PubMed PubMedCentral
  19.Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S et al (2004) Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. Circulation 110:1492–1498PubMed PubMedCentral CrossRef
  20.Maeda K, Cao H, Kono K, Gorgun CZ, Furuhashi M et al (2005) Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab 1:107–119PubMed CrossRef
  21.Schug TT, Berry DC, Toshkov IA, Cheng L, Nikitin AY et al (2008) Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. Proc Natl Acad Sci USA 105:7546–7551PubMed PubMedCentral CrossRef
  22.Schug TT, Berry DC, Shaw NS, Travis SN, Noy N (2007) Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 129:723–733PubMed PubMedCentral CrossRef
  23.Liu RZ, Graham K, Glubrecht DD, Germain DR, Mackey JR et al (2011) Association of FABP5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy. Am J Pathol 178:997–1008PubMed PubMedCentral CrossRef
  24.Fang LY, Wong TY, Chiang WF, Chen YL (2010) Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma. J Oral Pathol Med 39:342–348PubMed CrossRef
  25.Kannan-Thulasiraman P, Seachrist DD, Mahabeleshwar GH, Jain MK, Noy N (2010) Fatty acid-binding protein 5 and PPARbeta/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growth. J Biol Chem 285:19106–19115PubMed PubMedCentral CrossRef
  26.Jaffe EA, Nachman RL, Becker CG, Minick CR (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745–2756PubMed PubMedCentral CrossRef
  27.Altiok O, Yasumatsu R, Bingol-Karakoc G, Riese RJ, Stahlman MT et al (2006) Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia. Am J Respir Crit Care Med 173:318–326PubMed PubMedCentral CrossRef
  28.Yasumatsu R, Altiok O, Benarafa C, Yasumatsu C, Bingol-Karakoc G et al (2006) SERPINB1 upregulation is associated with in vivo complex formation with neutrophil elastase and cathepsin G in a baboon model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 291:L619–L627PubMed CrossRef
  29.Liang CC, Park AY, Guan JL (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2:329–333PubMed CrossRef
  30.Humphries MJ (2001) Cell adhesion assays. Mol Biotechnol 18:57–61PubMed CrossRef
  31.Dumartin L, Quemener C, Laklai H, Herbert J, Bicknell R et al (2010) Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells. Gastroenterology 138:1595–1606, 1606 e1591–e1598
  32.Talbot NC, Blomberg LA, Mahmood A, Caperna TJ, Garrett WM (2007) Isolation and characterization of porcine visceral endoderm cell lines derived from in vivo 11-day blastocysts. In Vitro Cell Dev Biol Anim 43:72–86PubMed CrossRef
  33.Ha MK, Chung KY, Lee JH, Bang D, Park YK et al (2004) Expression of psoriasis-associated fatty acid-binding protein in senescent human dermal microvascular endothelial cells. Exp Dermatol 13:543–550PubMed CrossRef
  34.Jiang B, Liang P, Zhang B, Huang X, Xiao X (2009) Enhancement of PPAR-beta activity by repetitive low-grade H(2)O(2) stress protects human umbilical vein endothelial cells from subsequent oxidative stress-induced apoptosis. Free Radic Biol Med 46:555–563PubMed CrossRef
  35.Piqueras L, Reynolds AR, Hodivala-Dilke KM, Alfranca A, Redondo JM et al (2007) Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis. Arterioscler Thromb Vasc Biol 27:63–69PubMed CrossRef
  36.Muller-Brusselbach S, Komhoff M, Rieck M, Meissner W, Kaddatz K et al (2007) Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient mice. EMBO J 26:3686–3698PubMed PubMedCentral CrossRef
  37.Graham TL, Mookherjee C, Suckling KE, Palmer CN, Patel L (2005) The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(−/−) mice. Atherosclerosis 181:29–37PubMed CrossRef
  38.Berry DC, Noy N (2009) All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor. Mol Cell Biol 29:3286–3296PubMed PubMedCentral CrossRef
  39.Shearer BG, Steger DJ, Way JM, Stanley TB, Lobe DC et al (2008) Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist. Mol Endocrinol 22:523–529PubMed CrossRef
  40.Tan NS, Shaw NS, Vinckenbosch N, Liu P, Yasmin R et al (2002) Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol 22:5114–5127PubMed PubMedCentral CrossRef
  41.Morgan E, Kannan-Thulasiraman P, Noy N (2010) Involvement of fatty acid binding protein 5 and PPARbeta/delta in prostate cancer cell growth. PPAR Res. doi:10.​1155/​2010/​234629
  
• 作者单位：Chen-Wei Yu (1) (5)
  Xiaoliang Liang (1)
  Samantha Lipsky (1)
  Cagatay Karaaslan (1) (6)
  Harry Kozakewich (2)
  Gokhan S. Hotamisligil (3)
  Joyce Bischoff (4)
  Sule Cataltepe (1)
  
  1. Department of Pediatric Newborn Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
  5. Department of Obstetrics and Gynecology, College of Medicine and Hospital, National Taiwan University, Taipei, Taiwan
  6. Department of Molecular Biology, Hacettepe University, Beytepe, Ankara, Turkey
  2. Department of Pathology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
  3. Department of Genetics and Complex Diseases and Sabri Ülker Center, Harvard T.H. Chan School of Public Health, Boston, MA, USA
  4. Vascular Biology Program and Department of Surgery, Harvard Medical School, Boston, MA, USA
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Oncology
  Cancer Research
  Cell Biology
  Cardiology
  Ophthalmology
  
• 出版者：Springer Netherlands
• ISSN：1573-7209

文摘

Fatty acid-binding proteins (FABP) are small molecular mass intracellular lipid chaperones that are expressed in a tissue-specific manner with some overlaps. FABP4 and FABP5 share ~55 % amino acid sequence homology and demonstrate synergistic effects in regulation of metabolic and inflammatory responses in adipocytes and macrophages. Recent studies have shown that FABP4 and FABP5 are also co-expressed in a subset of endothelial cells (EC). FABP4, which has a primarily microvascular distribution, enhances angiogenic responses of ECs, including proliferation, migration, and survival. However, the vascular expression of FABP5 has not been well characterized, and the role of FABP5 in regulation of angiogenic responses in ECs has not been studied to date. Herein we report that while FABP4 and FABP5 are co-expressed in microvascular ECs in several tissues, FABP5 expression is also detected in ECs of larger blood vessels. In contrast to FABP4, EC-FABP5 levels are not induced by VEGF-A or bFGF. FABP5 deficiency leads to a profound impairment in EC proliferation and chemotactic migration. These effects are recapitulated in an ex vivo assay of angiogenesis, the aortic ring assay. Interestingly, in contrast to FABP4-deficient ECs, FABP5-deficient ECs are significantly more resistant to apoptotic cell death. The effect of FABP5 on EC proliferation and survival is mediated, only in part, by PPARδ-dependent pathways. Collectively, these findings demonstrate that EC-FABP5, similar to EC-FABP4, promotes angiogenic responses under certain conditions, but it can also exert opposing effects on EC survival as compared to EC-FABP4. Thus, the balance between FABP4 and FABP5 in ECs may be important in regulation of angiogenic versus quiescent phenotypes in blood vessels. Keywords FABP4 FABP5 Angiogenesis Endothelial cell PPAR Apoptosis Cell survival Aortic ring assay